Literature DB >> 23115232

Reduced PDZ interactions of rescued ΔF508CFTR increases its cell surface mobility.

Cathleen D Valentine1, Gergely L Lukacs, Alan S Verkman, Peter M Haggie.   

Abstract

Deletion of phenylalanine 508 (ΔF508) in the cystic fibrosis transmembrane conductance regulator (CFTR) plasma membrane chloride channel is the most common cause of cystic fibrosis (CF). Though several maneuvers can rescue endoplasmic reticulum-retained ΔF508CFTR and promote its trafficking to the plasma membrane, rescued ΔF508CFTR remains susceptible to quality control mechanisms that lead to accelerated endocytosis, ubiquitination, and lysosomal degradation. To investigate the role of scaffold protein interactions in rescued ΔF508CFTR surface instability, the plasma membrane mobility of ΔF508CFTR was measured in live cells by quantum dot single particle tracking. Following rescue by low temperature, chemical correctors, thapsigargin, or overexpression of GRASP55, ΔF508CFTR diffusion was more rapid than that of wild-type CFTR because of reduced interactions with PDZ domain-containing scaffold proteins. Knock-down of the plasma membrane quality control proteins CHIP and Hsc70 partially restored ΔF508CFTR-scaffold association. Quantitative comparisons of CFTR cell surface diffusion and endocytosis kinetics suggested an association between reduced scaffold binding and CFTR internalization. Our surface diffusion measurements in live cells indicate defective scaffold interactions of rescued ΔF508CFTR at the cell surface, which may contribute to its defective peripheral processing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23115232      PMCID: PMC3527949          DOI: 10.1074/jbc.M112.421172

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking.

Authors:  Maxime Dahan; Sabine Lévi; Camilla Luccardini; Philippe Rostaing; Béatrice Riveau; Antoine Triller
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

2.  Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells.

Authors:  Marie E Egan; Judith Glöckner-Pagel; Catherine Ambrose; Paula A Cahill; Lamiko Pappoe; Naomi Balamuth; Edward Cho; Susan Canny; Carsten A Wagner; John Geibel; Michael J Caplan
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

Review 3.  CFTR: folding, misfolding and correcting the ΔF508 conformational defect.

Authors:  Gergely L Lukacs; A S Verkman
Journal:  Trends Mol Med       Date:  2011-12-03       Impact factor: 11.951

4.  A PDZ-interacting domain in CFTR is an apical membrane polarization signal.

Authors:  B D Moyer; J Denton; K H Karlson; D Reynolds; S Wang; J E Mickle; M Milewski; G R Cutting; W B Guggino; M Li; B A Stanton
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation.

Authors:  G C Meacham; C Patterson; W Zhang; J M Younger; D M Cyr
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

6.  PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator.

Authors:  Agnieszka Swiatecka-Urban; Marc Duhaime; Bonita Coutermarsh; Katherine H Karlson; James Collawn; Michal Milewski; Garry R Cutting; William B Guggino; George Langford; Bruce A Stanton
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

7.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.

Authors:  G M Denning; M P Anderson; J F Amara; J Marshall; A E Smith; M J Welsh
Journal:  Nature       Date:  1992-08-27       Impact factor: 49.962

8.  Monomeric CFTR in plasma membranes in live cells revealed by single molecule fluorescence imaging.

Authors:  Peter M Haggie; A S Verkman
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

9.  COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments.

Authors:  M Benharouga; M Haardt; N Kartner; G L Lukacs
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

10.  Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes.

Authors:  Manu Sharma; Francesca Pampinella; Csilla Nemes; Mohamed Benharouga; Jeffrey So; Kai Du; Kristi G Bache; Blake Papsin; Noa Zerangue; Harald Stenmark; Gergely L Lukacs
Journal:  J Cell Biol       Date:  2004-03-08       Impact factor: 10.539

View more
  11 in total

1.  Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product.

Authors:  Peter M Haggie; Puay-Wah Phuan; Joseph-Anthony Tan; Haijin Xu; Radu G Avramescu; Doranda Perdomo; Lorna Zlock; Dennis W Nielson; Walter E Finkbeiner; Gergely L Lukacs; Alan S Verkman
Journal:  J Biol Chem       Date:  2016-11-28       Impact factor: 5.157

2.  CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR.

Authors:  Yiting Wang; Jia Liu; Avgi Loizidou; Luc A Bugeja; Ross Warner; Bethan R Hawley; Zhiwei Cai; Ashley M Toye; David N Sheppard; Hongyu Li
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

3.  Single Quantum Dot Tracking Illuminates Neuroscience at the Nanoscale.

Authors:  Oleg Kovtun; Ian D Tomlinson; Danielle M Bailey; Lucas B Thal; Emily J Ross; Lauren Harris; Michael P Frankland; Riley S Ferguson; Zachary Glaser; Jonathan Greer; Sandra J Rosenthal
Journal:  Chem Phys Lett       Date:  2018-06-19       Impact factor: 2.328

Review 4.  Hallmarks of therapeutic management of the cystic fibrosis functional landscape.

Authors:  Margarida D Amaral; William E Balch
Journal:  J Cyst Fibros       Date:  2015-10-29       Impact factor: 5.482

5.  The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Uses its C-Terminus to Regulate the A2B Adenosine Receptor.

Authors:  Michael J Watson; Shernita L Lee; Abigail J Marklew; Rodney C Gilmore; Martina Gentzsch; Maria F Sassano; Michael A Gray; Robert Tarran
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

6.  Sec16A is critical for both conventional and unconventional secretion of CFTR.

Authors:  He Piao; Jiyoon Kim; Shin Hye Noh; Hee-Seok Kweon; Joo Young Kim; Min Goo Lee
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

7.  In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.

Authors:  Pascal Trouvé; Emmanuelle Génin; Claude Férec
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

Review 8.  Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.

Authors:  Samuel Estabrooks; Jeffrey L Brodsky
Journal:  Int J Mol Sci       Date:  2020-01-10       Impact factor: 5.923

9.  Stabilizing rescued surface-localized δf508 CFTR by potentiation of its interaction with Na(+)/H(+) exchanger regulatory factor 1.

Authors:  Kavisha Arora; Changsuk Moon; Weiqiang Zhang; Sunitha Yarlagadda; Himabindu Penmatsa; Aixia Ren; Chandrima Sinha; Anjaparavanda P Naren
Journal:  Biochemistry       Date:  2014-06-19       Impact factor: 3.162

Review 10.  Decoding F508del misfolding in cystic fibrosis.

Authors:  Xiaodong Robert Wang; Chenglong Li
Journal:  Biomolecules       Date:  2014-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.